Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan
Digestive Endoscopy · 2026
DOI: 10.1111/den.70130 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Digestive Endoscopy, 2026. Verfasst von Daisuke Yamaguchi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. Hauptthemen laut MEDLINE: Colonoscopy, Midazolam, Hypnotics and Sedatives, Benzodiazepines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mundipharma K.K. (Tokyo, Japan).
Abstract (Originalsprache)
Objectives
Sedation during colonoscopy is becoming increasingly important. Remimazolam, an ultra‐short‐acting benzodiazepine, has a shorter pharmacokinetic half‐life than that of midazolam. This study examined whether remimazolam provides superior sedation during colonoscopy in Japanese patients.
Methods
This prospective, multicenter, randomized, single‐blind, controlled trial included adults (18–80 years) scheduled for sedated colonoscopy. Participants were randomized to the remimazolam and midazolam groups. The primary outcome was the proportion of ambulatory patients 5 min after colonoscopy. Secondary outcomes were successful pre‐procedure sedation (Modified Observer's Assessment of Alertness/Sedation [MOAA/S] ≤ 4), recovery time, total sedative dose, and adverse events.
Results
Forty patients were enrolled and analyzed (remimazolam, n = 19; midazolam, n = 21). At 5 min post‐colonoscopy, ambulation was achieved in 100% (19/19) of remimazolam patients and 19.1% (4/21) of midazolam patients ( p < 0.0001). The median time [interquartile range (IQR)] from procedure end to full alertness (MOAA/S = 5) was 0 [0–0] min for remimazolam and 10 [5–20] min for midazolam ( p < 0.0001). The median time [IQR] from procedure end to independent ambulation was 0 [0–5] min for remimazolam and 20 [10–30] min for midazolam ( p < 0.001). Pre‐procedure sedation was successful (MOAA/S ≤ 4) in 100% of both groups. The median amount [IQR] of total sedative dose was 5 [4–6] mg for remimazolam and 3 [3] mg for midazolam. Hypoxemia occurred in 5.3% and 9.5% of patients in the remimazolam and midazolam groups, respectively.
Conclusions
Compared with midazolam, remimazolam resulted in significantly faster recovery after colonoscopy in Japanese patients, with comparable achievement of target sedation and a low incidence of hypoxemia. Clinical Registration Trial number: jRCTs071240062
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
- Department of Gastroenterology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan.
- Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
- Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Clinical Research Center, Saga University Hospital, Saga, Japan.
ORCID-Profile: Daisuke Yamaguchi, Hisatomo Ikehara, Yosuke Minoda, Mitsuru Esaki, Motohiro Esaki
Förderung
- Mundipharma K.K. (Tokyo, Japan)
Zitieren
APA
Yamaguchi, D., Ichijima, R., Ikehara, H., Minoda, Y., Esaki, M., Takamori, A., Yoh, A., Shirouzu, M., Sadashima, K., Fujimura, Y., Shimamura, T., Takedomi, H., Akutagawa, T., Tsuruoka, N., Sakata, Y., Wada, T., Kusano, C., Shimoda, R., & Esaki, M. (2026). Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan. Digestive Endoscopy. https://doi.org/10.1111/den.70130
Vancouver
Yamaguchi D, Ichijima R, Ikehara H, Minoda Y, Esaki M, Takamori A, et al. Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan. Digestive Endoscopy. 2026. doi:10.1111/den.70130
BibTeX
@article{Yamaguchi2026,
author = {Yamaguchi, Daisuke and Ichijima, Ryoji and Ikehara, Hisatomo and Minoda, Yosuke and Esaki, Mitsuru and Takamori, Ayako and Yoh, Akiyoshi and Shirouzu, Moeko and Sadashima, Kento and Fujimura, Yutaro and Shimamura, Takuya and Takedomi, Hironobu and Akutagawa, Takashi and Tsuruoka, Nanae and Sakata, Yasuhisa and Wada, Takuya and Kusano, Chika and Shimoda, Ryo and Esaki, Motohiro},
title = {Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan},
journal = {Digestive Endoscopy},
year = {2026},
doi = {10.1111/den.70130}
}
EUVIMED